Search
Risedronic acid
go.drugbank.com/drugs/DB00884ApprovedInvestigationalRisedronic acid is a third generation bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease[FDA Label] . It functions by preventing resorption of bone[FDA Label] .
Mixtures: RISEPLUS D3 35 MG/5600 IU EFERVESAN TABLET, 4 ADET, RISEPLUS D3 35 MG/2800 IU EFERVESAN TABLET, 12 ADETProducts: Actonel Dr, Aa-risedronate DrOndansetron
go.drugbank.com/drugs/DB00904ApprovedInvestigationalWithdrawn[L5221] The FDA withdrew its approval for the use of all intravenous drug products containing more than 16 mg of ondansetron hydrochloride in a single dose, due to a high risk of QT prolongation.
Products: VONAU FLASH® 8 MG TABLETA DE DESINTEGRACION ORAL, VONAU FLASH® 4 MG TABLETA DE DESINTEGRACION ORALDe Novo Triacylglycerol Biosynthesis TG(16:0/16:0/18:2(9Z,12Z))
smpdb.ca/view/SMP0015907Metabolic(Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:1(9Z))
smpdb.ca/view/SMP0015927Metabolic(Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.
De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:0/18:1(9Z))
smpdb.ca/view/SMP0015967Metabolic(Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.
De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:0/20:1(11Z))
smpdb.ca/view/SMP0015968Metabolic(Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.
De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:1(9Z)/20:0)
smpdb.ca/view/SMP0015982Metabolic(Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.
De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:0/20:1(11Z))
smpdb.ca/view/SMP0015995Metabolic(Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.
De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/20:0/20:0)
smpdb.ca/view/SMP0016012Metabolic(Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.
De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/16:0/18:1(11Z))
smpdb.ca/view/SMP0016036Metabolic(Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.